BioSpace News Archive

First anchor investor in upcoming Series D financing round commits EUR10 million and intends to support Promethera broadly in R&D, BD and through its Medical Network in Asia

Biotage AB – for the upcoming Annual General Meeting 2019 in Biotage AB, the Nomination Committee today publishes its proposal that the current CEO Torben Jørgensen shall be elected as a new board member.

New Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims

Accelerating the growth of the cell culture media business

New fund will invest growth capital in Atlas-backed biotech companies

Mark H.N. Corrigan, MD to Succeed William Hunter, MD as Chief Executive Officer by the End of the First Quarter 2019

EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), the leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, is excited to announce that EVIO Canada’s Keystone Labs is now accepting legal cannabis in the form of dry flower and oil extracts for mandatory pesticide testing.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference

Aimmune Therapeutics (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that CEO Jayson Dallas, M.D., will present a company overview at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2019, at 3:00 p.m. Pacific Time.

Twist Bioscience (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that Emily Leproust, Ph.D., CEO and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 1:30 p.m. Pacific Time in San Francisco.